News Posts List
Cabozantinib to be Featured in Nine Presentations at ASCO
04/28/2012
"The nine data presentations at this year's ASCO Annual Meeting are indicative of the growing depth and breadth of cabozantinib's global clinical development program..."
AVEO set to move from start-up to producer
04/28/2012
A decade after AVEO Pharmaceuticals was founded...
Renal cell carcinoma metastasis to the ciliary body responds to proton beam radiotherapy
04/28/2012
We report an unexpected presentation of metastatic renal cell carcinoma (RCC) to the ciliary body and an interesting response to proton beam radiotherapy.
Kidney Cancer Patients Fare Better With Tumor Removal Only
04/28/2012
Kidney cancer patients who have only the tumor removed, not the entire kidney, have higher survival rates, a new study finds.
Role of immunohistochemistry in diagnosing renal neoplasms
04/28/2012
With the refinement of molecular and histologic classifications of renal neoplasms and the availability of more-effective molecular targeted therapy for specific renal neoplasms, immunohistochemical techniques will play an increasingly important role in the diagnosis of renal neoplasm. During the past few decades, many markers have been evaluated for their role in the diagnosis, prognosis, and prediction of treatment for renal neoplasms. The number of useful markers in our routine practice continues to increase.
Systemic Therapy in Renal Cell Carcinoma: Advancing Paradigms
04/28/2012
This article will review the recent advances that form the current framework of therapy for RCC, as well as summarize key areas of progress and innovation in the evolving treatment paradigms for this disease.
Tampa woman fights kidney cancer with a strong spirit
04/28/2012
Doctor Spiess specializes in treating kidney cancer patients. Linda was a perfect candidate for one of the new surgical treatments performed at The Moffitt Cancer Center.
The Doctor Will See You-If You're Quick
04/28/2012
70 percent of doctors reported that since they began practicing medicine, the bond with their patients has eroded.
Afinitor® approved by FDA as first medication to treat patients with non-cancerous kidney tumors associated with TSC
04/27/2012
"Renal angiomyolipomas are one of the greatest causes of morbidity and mortality in adult TSC patients and can be one of the most challenging aspects of the disease to treat."
Cancer patient denied Avastin in Wales
04/26/2012
Medical groups are warning that cancer patients in Wales, Scotland and Northern Ireland are not getting the same access to new drugs as patients in England.
News Feed